Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Observational Study of Metformin Hydrochloride and Empagliflozin Tablets (Enshuangping) in the Treatment of Type 2 Diabetes

NCT07003191 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT07003191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07003191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Observational Study of Metformin Hydrochloride and Empagliflozin Tablets (Enshuangping) in the Treatment of Type 2 Diabetes
Lead sponsor
Sun Yat-sen University
Phase
Observational
Overall status
Active, not recruiting
Start date
August 2, 2023
Completion date
December 31, 2025
Enrollment
2,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes